About Aster Medipharm Private Limited
Data last updated:
Aster Medipharm Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 December 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2009PTC030503. Its GSTIN is 08AAJCA3531E1ZZ (Rajasthan).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Hemant Kumar Pareek (Whole-Time Director) and Jitendra Kumar Sharma (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor North Part Of Plot No 66 B Vishkarma Industrial Area, Jaipur, Rajasthan, India – 302013.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.79 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹26.61 Lakh (net margin 1.3%) and EBITDA of ₹58.78 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 17% over five years.
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aster Medipharm. As per MCA filings, the company has open charges of ₹85 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website astermedipharm.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressFirst Floor North Part Of Plot No 66 B Vishkarma Industrial Area, Jaipur, Rajasthan, India – 302013
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aster Medipharm Private Limited
The main business activity of Aster Medipharm is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aster Medipharm Private Limited FY 2025 filings available
Aster Medipharm Private Limited reported revenue of ₹20.79 Cr (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aster Medipharm Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 13% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aster Medipharm Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹58.78 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹26.61 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aster Medipharm Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aster Medipharm are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Aster Medipharm Private Limited
Aster Medipharm Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Epoch Pharmacuticals Private Limited | •••• | •••• | •••• | •••• | - | Vadodara, Gujarat, India |
| Panacea Life Sciences Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Macsur Pharmaa (India) Private Limited | •••• | •••• | •••• | •••• | - | Puduchery, Pondicherry, India |
| Maple Biotech Pvt Ltd | •••• | •••• | •••• | •••• | 21 | Pune, Maharashtra, India |
| Celsius Healthcare Private Limited | •••• | •••• | •••• | •••• | - | Delhi, India |
| Aster Medipharm Private Limited this company | •••• | •••• | •••• | •••• | - | Jaipur, Rajasthan, India |
| Snehal Pharma & Surgicals Private Limited | •••• | •••• | •••• | •••• | 29 | Mumbai, Maharashtra, India |
| Sheetal Chemicals Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Instant Remedies Private Limited | •••• | •••• | •••• | •••• | - | Chandigarh, India |
| Kesar Pharma Limited | •••• | •••• | •••• | •••• | 39 | Gandhinagar, Gujarat, India |
| Dewcare Concept Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Aster Medipharm by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Aster Medipharm Private Limited
Aster Medipharm Private Limited is audited by KAUSHIK AGRAWAL & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KAUSHIK AGRAWAL & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Aster Medipharm Private Limited
Aster Medipharm has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemant Kumar Pareek | Whole-Time Director | 12 Apr 2015 | 11 Years 5 Months | Current |
| Jitendra Kumar Sharma Also directs: Incepta-Prime Private Limited | Whole-Time Director | 15 Dec 2009 | 16 Years 9 Months | Current |
| Pawan Kumar Pareek Also directs: Incepta-Prime Private Limited | Whole-Time Director | 15 Dec 2009 | 16 Years 9 Months | Current |
Ownership and Shareholding of Aster Medipharm Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aster Medipharm Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 May 2023 | Others | ₹50 Lakh | Open |
| 23 Dec 2022 | Hdfc Bank Limited | ₹35 Lakh | Open |
Total charge records: 2 View all charges
MSME Payment Delays by Aster Medipharm Private Limited
Aster Medipharm Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 11 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Regent Regent Ajanta Biotech | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Aster Medipharm Private Limited
Aster Medipharm operates one associated brand: Aster Medipharm. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical franchising, product distribution, and medicinal services in India. | astermedipharm.com |
Employees and EPFO Compliance at Aster Medipharm Private Limited
Employment history and EPFO contributions of people linked to Aster Medipharm.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aster Medipharm Private Limited
Aster Medipharm Private Limited has 7 board changes on record since 2009: 3 appointments and 4 cessations. The latest: Hemant Kumar Pareek ceased to be Director on 31 Mar 2024.
Credit Ratings, Litigation & Regulatory Alerts for Aster Medipharm Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aster Medipharm Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aster Medipharm Private Limited
Aster Medipharm has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAJCA3531E1ZZ | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aster Medipharm Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aster Medipharm Private Limited
Aster Medipharm is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 December 2009 (17+ years old) and is registered under CIN U24232RJ2009PTC030503.
Aster Medipharm reported revenue of ₹20.79 Cr for FY 2025 (up 13% YoY).
Aster Medipharm has 3 current directors:
- Hemant Kumar Pareek - Whole-Time Director
- Jitendra Kumar Sharma - Whole-Time Director
- Pawan Kumar Pareek - Whole-Time Director
Aster Medipharm reported a net profit of ₹26.61 Lakh (net margin 1.3%) and EBITDA of ₹58.78 Lakh (EBITDA margin 2.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aster Medipharm is 15% over three years and 17% over five years. In the latest year (FY 2025) revenue rose 13%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aster Medipharm is 08AAJCA3531E1ZZ, registered in Rajasthan.
The CIN (Corporate Identification Number) of Aster Medipharm is U24232RJ2009PTC030503. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aster Medipharm was incorporated on 15 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Aster Medipharm by revenue are Epoch Pharmacuticals Private Limited, Panacea Life Sciences Limited, Macsur Pharmaa (India) Private Limited, Maple Biotech Pvt Ltd, Celsius Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).
Hemant Kumar Pareek ceased to be Director on 31 Mar 2024. Jitendra Kumar Sharma ceased to be Director on 31 Mar 2024. Pawan Kumar Pareek ceased to be Director on 31 Mar 2024. Aster Medipharm has 7 board changes on record in total.
Aster Medipharm has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 11 overdue payments to 2 micro and small suppliers. The latest return was filed on 30 May 2019.
Aster Medipharm can be reached through the website astermedipharm.in. Its registered office is in Jaipur, Rajasthan, India.